Developing an oral solid dosage product involves more than just formulation; it requires scientific expertise, regulatory knowledge, and effective project management throughout various stages, from formulation development to clinical evaluation and approval. Pharmaceutical companies often find it challenging to handle these tasks in-house due to the need for specialized expertise and global regulatory experience. CurexBio offers Contract Research Organization CRO support across the drug development journey, facilitating the transformation of formulations into clinically evaluated and regulatory-ready products.
Oral Solid Dosage Products
Oral solid dosage (OSD) products include pharmaceutical formulations such as
OSD formulations are popular drug delivery systems due to their convenience, stability, and patient acceptability. Successful development of an OSD product requires careful consideration of the active pharmaceutical ingredient, excipients, formulation characteristics, manufacturing process, bioavailability, stability, safety, efficacy, and regulatory requirements.
CRO assists in OSD development:
A CRO can serve as an extension of a pharmaceutical company’s team, allowing sponsors to utilize CRO expertise for specific activities or comprehensive development programs. This approach optimizes resources, manages timelines, and provides access to specialized scientific and clinical skills. A typical development pathway includes stages such as Preformulation, Formulation Development, Analytical Development, Manufacturing/Scale-Up, Stability, Bioequivalence/Clinical Studies, and Regulatory Submission, each generating data critical for regulatory decisions.
- Preformulation and Formulation Development
The formulation strategy for an Active Pharmaceutical Ingredient (API) begins with understanding its key physicochemical properties, including solubility, permeability, particle size, and excipient compatibility. This knowledge informs considerations such as dose requirements, drug release characteristics, and stability. Formulation scientists can develop and evaluate prototypes using various methods, including immediate-release and modified-release technologies. CurexBio offers support to pharmaceutical companies in designing formulation development programs that align with their product profiles and development strategies.
- Analytical Development and Method Validation
A robust analytical strategy is crucial for validating the identity, strength, quality, purity, and performance of pharmaceutical products. Key analytical activities include the development and validation of methods for assay, related substances, dissolution, content uniformity, identification, degradation products, and stability-indicating parameters. Effective analytical methods support formulation characterization, stability studies, batch release, and regulatory documentation. CurexBio collaborates with its scientific network to assist sponsors in developing suitable analytical and quality strategies during product development.
- Process Development and Scale-Up
A successful laboratory formulation may not translate directly to larger-scale manufacturing, necessitating a thorough evaluation of critical material attributes and process parameters, including mixing, granulation, compression, coating, reproducibility, and in-process controls. Collaborating with a CRO can aid in coordinating development activities and identifying potential risks, ensuring the goal is to create a reliable manufacturing process that consistently meets product quality standards.
- Stability Studies
Stability testing assesses how a product’s quality varies over time under specific storage conditions. For an OSD product, it evaluates factors like assay, degradation products, dissolution, physical appearance, moisture, hardness, and packaging performance. The data gathered informs about shelf life and optimal storage conditions, making a solid stability strategy crucial for product development and regulatory compliance.
- Bioequivalence and Clinical Development
Demonstrating bioequivalence is crucial for regulatory approval of generic and other development programs. Bioequivalence studies assess whether the test and reference products provide similar active ingredient exposure under defined conditions. CRO support may encompass clinical study planning, protocol development, site coordination, regulatory submissions, subject recruitment, clinical trial management, pharmacokinetic support, data management, statistical analysis, and study reporting. For innovative OSD products, CROs may also assist with broader clinical development activities based on the product’s stage and regulatory pathway.
- Regulatory Strategy and Submission Support
Regulatory requirements vary by product, indication, development pathway, and market, necessitating an early consideration of regulatory strategy. CROs assist sponsors in coordinating regulatory strategy, submission planning, documentation, responses to regulatory queries, interactions with authorities, and submission readiness. The aim is to ensure that scientific evidence from development is well-organized into a coherent regulatory package.
Advantages of CRO
Working with a CRO allows pharmaceutical and biotechnology companies to leverage specialized expertise and infrastructure, reducing the need to develop every capability in-house. Key advantages include access to external resources and expert knowledge.
At CurexBio, we emphasize that effective product development demands coordination, scientific expertise, regulatory knowledge, and dependable execution. Our CRO solutions assist pharmaceutical and biotechnology companies in essential areas of clinical and regulatory development.
Clinical Trial Services | Regulatory Solutions | Biosimilar Programs | Clinical Site Networks | Clinical Development Support
CurexBio offers assistance across various stages of drug development, including generic oral solid dosage products, complex formulations, bioequivalence programs, and regulatory submissions.
Contact us at bd@curexbio.com for OSD development assistance.
The journey from a concept to an approved pharmaceutical product encompasses various scientific, clinical, operational, and regulatory milestones. A suitable CRO partner can streamline this process, ensuring a focus on delivering quality pharmaceutical products to patients. For oral solid dosage development, consider CurexBio to discuss how its capabilities in clinical, regulatory, biosimilar, and global site-network can enhance your development journey.
